Aspirin fails to prevent recurrence after colorectal liver metastasis treatment

Daily low-dose aspirin did not lower the risk of cancer returning in patients treated for colorectal cancer that had spread to the liver, according to a randomised trial led by Sheraz Yaqub of the University of Oslo and Oslo University Hospital. Patients given aspirin also had lower overall survival and more serious…